☆ 4.6 Article

Digital health technologies and Alzheimer's disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?

ALZHEIMERS RESEARCH & THERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Lecanemab in Early Alzheimer's Disease

Christopher H. van Dyck et al.

Summary: Lecanemab, a humanized monoclonal antibody, reduced amyloid markers and showed improvement in cognition and function in early Alzheimer's disease patients. However, it also resulted in adverse events. Longer trials are needed to determine its efficacy and safety in early Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies

Olalekan Lee Aiyegbusi et al.

BMJ EVIDENCE-BASED MEDICINE (2023)

Add to Collection

Review Pharmacology & Pharmacy

A systematic review of methods used to conduct decentralised clinical trials

Amy Rogers et al.

Summary: This study aims to evaluate the design and conduct of decentralised clinical trials using quantitative and qualitative approaches. The quantitative analysis included 45 randomised clinical trials, with the primary outcome being the number of randomised participants. The qualitative analysis included 117 documents discussing or evaluating decentralised clinical trials. The results showed heterogeneity in the design and reporting of trials, and insufficient evidence to support the effectiveness of DCT methods in trial recruitment. The qualitative analysis identified four themes: value, burden, safety and equity. Further research on participant and stakeholder experiences of DCTs is recommended to maximize potential benefits.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Add to Collection

Article Neurosciences

Recruitment for Remote Decentralized Studies in Parkinson's Disease

Taylor L. Myers et al.

Summary: Recruitment of large, geographically dispersed remote cohorts through video visits is feasible. Interest in participation in future remote decentralized PD studies is high, but more efforts are needed to attract diverse participants.

JOURNAL OF PARKINSONS DISEASE (2022)

Add to Collection

Review Medicine, General & Internal

Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia

Lucy C. Beishon et al.

Summary: The diagnostic accuracy of remote cognitive assessments, such as telephone and video-based screening, is still unclear. There is a need for more research to determine the accuracy of these assessments and to understand the differences between remote and face-to-face tests. The available data do not allow for a preferred test to be recommended.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)

Add to Collection

Article Health Care Sciences & Services

ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer's disease and Alzheimer's disease-related dementias clinical trials

Gustavo A. Jimenez-Maggiora et al.

Summary: The Alzheimer's Therapeutic Research Institute (ATRI) has developed a novel clinical data management system to address the complex requirements of multicenter clinical trials for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRDs). The system offers a variety of modular capabilities, supports study-specific configuration, and facilitates effective communication and collaboration among study teams.

JAMIA OPEN (2022)

Add to Collection

Letter Geriatrics & Gerontology

Frailty, e-health and prevention of late-onset Alzheimer disease and related disorders: it is time to take action

Olivier Beauchet et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Add to Collection

Article Clinical Neurology

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

S. Budd Haeberlein et al.

Summary: Aducanumab showed significant changes in early Alzheimer's disease patients in one trial, but did not meet primary or secondary endpoints in another study. Both trials demonstrated a dose- and time-dependent reduction in pathophysiological markers of Alzheimer's disease.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Remote Research and Clinical Trial Integrity During and After the Coronavirus Pandemic

Mary M. McDermott et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

Rema Raman et al.

Summary: Racial/ethnic groups showed differences in recruitment sources, reasons for screen failure, and overall probability of eligibility in a preclinical AD trial. These results emphasize the necessity for improved recruitment strategies and careful consideration of eligibility criteria in planning preclinical AD clinical trials.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Clinical Neurology

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

Lisa Vermunt et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Add to Collection

Editorial Material Clinical Neurology

The New Normal in Clinical Trials: Decentralized Studies

E. Ray Dorsey et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Article Neurosciences

Challenges to and Facilitators of Recruitment to an Alzheimer's Disease Clinical Trial: A Qualitative Interview Study

Clare Clement et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Add to Collection

Article Clinical Neurology

Dementia in western Europe: epidemiological evidence and implications for policy making

Yu-Tzu Wu et al.

LANCET NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

Jeffrey L. Cummings et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Add to Collection

Article Geriatrics & Gerontology

Classification and Epidemiology of MCI

Rosebud Roberts et al.

CLINICS IN GERIATRIC MEDICINE (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.